Latest Antibody Stories
ROCHESTER, N.Y., Dec.
OXFORD, England and BERLIN, November 25, 2014 /PRNewswire/ -- Oxford BioTherapeutics and Berlin Chemie/ Menarini Biotech/ Menarini Ricerche (belonging to Menarini Group)
New Study Exposes How ZMapp Therapy Attacks Virus and Suggests Strategies to Improve It LA JOLLA, Calif., Nov.
MAB242P, the most recently developed antibody, is the first MBS antibody to recognize both GI and GII strains of norovirus.
WORCESTER, Mass. and TORONTO, Oct.
Broad Bi-Specific Antibody Collaboration Now Includes Targets that Could Lead to New Cancer Immunotherapies INDIANAPOLIS and VANCOUVER, Oct. 22, 2014 /CNW/ - Zymeworks Inc.
PhosImmune and PureMHC Working Together On Immunotherapies for Cancer CHARLOTTESVILLE, Va. and AUSTIN, Texas, Oct. 22, 2014 /PRNewswire/ -- PhosImmune Inc.
Management Responds To Inquiries Concerning Discovery Capabilities For Anti-Ebola Treatments SAN DIEGO, Oct. 21, 2014 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc.
- A trick or prank.
More Images (4 images) »